US Stock MarketDetailed Quotes

LGND Ligand Pharmaceuticals

Watchlist
  • 108.550
  • +2.790+2.64%
Close Apr 24 16:00 ET
  • 108.550
  • 0.0000.00%
Post 16:05 ET
2.09BMarket Cap-493.41P/E (TTM)

Ligand Pharmaceuticals Key Stats

Ligand Pharmaceuticals Q1 2025 Estimates Date

Currency:USDMay 8, 2025

Estimate YoY
Revenue
37.84M
+22.16%
EPS
0.21
-95.49%
Strong Buy

Apr 10, 2025

Ligand Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 44.305M--
May 8, 20252025/Q1-- / 37.842M--
Feb 27, 20252024/Q442.812M / 39.026M--
Nov 7, 20242024/Q351.812M / 40.600M--
Aug 6, 20242024/Q241.531M / 34.264M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 44.305M--
May 8, 20252025/Q1-- / 37.842M--
Feb 27, 20252024/Q442.812M / 39.026M--
Nov 7, 20242024/Q351.812M / 40.600M--
Aug 6, 20242024/Q241.531M / 34.264M--

Unlock Free Earnings Estimates

Ligand Pharmaceuticals Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More